YU3101A - Farmaceutska formulacija suspenzije koja obuhvata amoksicilin, klavulonsku kiselinu i celulozu - Google Patents

Farmaceutska formulacija suspenzije koja obuhvata amoksicilin, klavulonsku kiselinu i celulozu

Info

Publication number
YU3101A
YU3101A YU3101A YU3101A YU3101A YU 3101 A YU3101 A YU 3101A YU 3101 A YU3101 A YU 3101A YU 3101 A YU3101 A YU 3101A YU 3101 A YU3101 A YU 3101A
Authority
YU
Yugoslavia
Prior art keywords
cellulose
amoxycillin
suspension formulation
pharmaceutical suspension
clavulanic acid
Prior art date
Application number
YU3101A
Other languages
English (en)
Inventor
Bojan Kofler
Mateja Kovačič
Original Assignee
Lek Pharmaceutical & Chemical Co.D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceutical & Chemical Co.D.D. filed Critical Lek Pharmaceutical & Chemical Co.D.D.
Publication of YU3101A publication Critical patent/YU3101A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Tečna formulacija farmaceutske suspenzije u vodi koja kao aktivni sastojak sadrži amoksicilin trihidrat i kalijum klavulonat, uključuje efikasnu količinu celuloze kao potporne supstance i po slobodnom izboru dalje ekscipijente.[A liquid aqueous pharmaceutical suspension formulation containing as active ingredient amoxycillin trihydrate and potassium clavulanate, including an effective quantity of cellulose as sole filler and optionally including further excipients.
YU3101A 1998-07-17 1999-07-15 Farmaceutska formulacija suspenzije koja obuhvata amoksicilin, klavulonsku kiselinu i celulozu YU3101A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9815532.8A GB9815532D0 (en) 1998-07-17 1998-07-17 Pharmaceutical suspension formulation

Publications (1)

Publication Number Publication Date
YU3101A true YU3101A (sh) 2003-10-31

Family

ID=10835666

Family Applications (1)

Application Number Title Priority Date Filing Date
YU3101A YU3101A (sh) 1998-07-17 1999-07-15 Farmaceutska formulacija suspenzije koja obuhvata amoksicilin, klavulonsku kiselinu i celulozu

Country Status (14)

Country Link
US (1) US6511972B1 (sh)
EP (1) EP1098633A1 (sh)
AU (1) AU762840B2 (sh)
CZ (1) CZ296003B6 (sh)
GB (1) GB9815532D0 (sh)
HR (1) HRPK20010048B1 (sh)
HU (1) HUP0103015A3 (sh)
PL (1) PL194393B1 (sh)
RU (1) RU2205639C2 (sh)
SK (1) SK286339B6 (sh)
UA (1) UA73720C2 (sh)
WO (1) WO2000003695A1 (sh)
YU (1) YU3101A (sh)
ZA (1) ZA200100463B (sh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004510A1 (es) 1995-09-07 1998-12-16 Smithkline Beecham Plc Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
GB2365337A (en) * 1999-04-13 2002-02-20 Beecham Pharma Amoxycillin and potassium clavulanate high dosage regimen
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
NL1014915C2 (nl) * 1999-04-13 2001-02-12 Beecham Pharm Pte Ltd Nieuwe behandelingsmethode.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
PT1078627E (pt) * 1999-08-20 2006-10-31 Glaxosmithkline Lab Sas Formulacao farmaceutica compreendendo amoxicilina e clavulanato
FR2797588B1 (fr) * 1999-08-20 2003-08-01 Smithkline Beecham Lab Formulation pharmaceutique a base d'amoxycilline et de clavulanate
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
MXPA03006565A (es) * 2001-01-23 2005-07-29 Gador Sa Composicion comprendiendo bisfosfonatos para la prevencion y/o tratamiento de enfermedades metabolicas de huesos, proceso para preparar tal composicion y el uso de la misma.
JP2006527726A (ja) * 2003-06-16 2006-12-07 グラクソ　グループ　リミテッド アモキシシリンおよびクラブラン酸塩を含む医薬製剤
US20080242725A1 (en) * 2004-03-01 2008-10-02 Janez Kerc Pharmaceutical Composition
TR201000686A1 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000687A1 (tr) * 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
US9254261B2 (en) 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2028A1 (fr) 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
JPH11510811A (ja) 1995-08-12 1999-09-21 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 医薬処方
DE69815833T2 (de) * 1997-02-14 2004-05-19 Laboratoire Glaxosmithkline S.A.S. Amoxicillin und clavulanat enthaltende arzneizubereitungen
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika

Also Published As

Publication number Publication date
PL194393B1 (pl) 2007-05-31
HUP0103015A3 (en) 2003-01-28
SK286339B6 (en) 2008-07-07
AU5049799A (en) 2000-02-07
CZ296003B6 (cs) 2005-12-14
UA73720C2 (en) 2005-09-15
EP1098633A1 (en) 2001-05-16
WO2000003695A1 (en) 2000-01-27
HRP20010048A2 (en) 2002-02-28
GB9815532D0 (en) 1998-09-16
SK842001A3 (en) 2001-09-11
US6511972B1 (en) 2003-01-28
PL345564A1 (en) 2001-12-17
HUP0103015A2 (hu) 2001-12-28
RU2205639C2 (ru) 2003-06-10
CZ2001217A3 (cs) 2001-08-15
HRPK20010048B1 (en) 2003-04-30
ZA200100463B (en) 2001-09-04
AU762840B2 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
YU3101A (sh) Farmaceutska formulacija suspenzije koja obuhvata amoksicilin, klavulonsku kiselinu i celulozu
EP1452172A3 (en) Multiple unit pharmaceutical preparation
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
AU7207098A (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
AU2274201A (en) Compounds and compositions for delivering active agents
WO2001032596A8 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
AU8199187A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
EP1232757A4 (en) MEDICINE FOR DISEASES ASSOCIATED WITH LOSS OF BONE SUBSTANCE
MY111136A (en) Oral formulations of an antifungal.
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
CA2294783A1 (fr) Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine
AU2084801A (en) Antiviral medication
MY132911A (en) Clear, injectable solution of an anesthetic compound
HUP0003840A2 (hu) Szabályozott hatóanyagleadású gyógyászati készítmények
AU2405401A (en) Nerve protective drugs
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
AU2603792A (en) Long acting injectable formulations containing hydrogenated castor oil
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
WO2004110441A8 (en) Pharmaceutical formulations comprising amoxicillin and clavulanate
TW200509990A (en) Pharmaceutical formulations